UNSPSC 85691919: Revision of autologous tissue substitute in sternum, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in sternum, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0PW007Z

UNSPSC 85691919 Revision of autologous tissue substitute in sternum, open approach, a Commodity code, shows no recent state and local procurement activity aligned with its nominal scope. The six recent opportunities tagged under this code span occupational medical surveillance for ferry workers, independent disability medical evaluations for public safety pension boards, surgical benefit carve-out programs for municipal employees, pharmacy benefit management, temporary health professional staffing, specialty and emergency medical services for detained youth, and an RFI for emergency and specialty services—none of which involve surgical revision of sterile tissue substitutes in the sternum. The mismatch suggests either misclassification by issuing bodies at the point of posting or a systematic classification error in the source data. State and local procurement offices frequently tag health services and healthcare administration opportunities with medical procedure codes when administrative systems lack precise alternative taxonomy, particularly where services span multiple clinical domains or do not fit cleanly within service-category frameworks.

The issuing bodies include county health systems (Santa Clara), county probation and correctional authorities (Harris County), county human resources and benefits divisions (Collier County), municipal pension boards and retirement offices (Phoenix), municipal employee benefits offices (Long Beach), and state transportation departments (Washington). Geographic activity spans California, Arizona, Florida, Washington, and Texas. The opportunities do not reflect procurement under the code's stated clinical scope; therefore, this code presents no actionable market signal for vendors targeting surgical device or tissue substitute contracts at state and local level.